Net revenues of $283.4 million declined 7.7 percent from last year’s revenues of $307.1 million. This decline was partially a result of difficult economic conditions and the on-going strength of the U.S. dollar versus most foreign currencies. During the second quarter of 2001, the Company experienced negative effects of changes in currency exchange rates of approximately 3 percent and price declines of almost 7 percent. Increases in newer product revenues of 13 percent over the prior year, were offset partially by declines in mature product revenues, for total volume increases of approximately 2 percent.
Data Storage and Information Management revenues declined $5.1 million, or 2.4 percent, to $206.3 million from $211.4 million a year ago. The most significant factor causing this decline was reduced sales of SuperDisk. Excluding SuperDisk hardware and media, Data Storage revenues would have increased 4.8 percent over second quarter 2000. Pricing pressures persisted throughout the period but were less than recent quarters.
Color Technologies revenues were $55.9 million as compared with $74.0 million a year ago. The $18.1 million decline from second quarter 2000 was primarily due to lower sales of analog proofing systems, and plates and film products.
Digital Solutions and Services second quarter 2001 revenues were $21.0 million as compared with $23.7 million a year ago. The $2.7 million decline from second quarter 2000 resulted primarily from the ongoing transition in the large format document imaging business from analog to digital, as well as declines in the Document Imaging business.
Gross profit in second quarter 2001 was $86.3 million or 30.5 percent of revenues, compared to $94.4 million, or 30.8 percent of revenues in the year earlier quarter. The gross margin percentage decrease resulted primarily from continued negative impacts from changes in foreign currency exchange rates, partially offset by productivity improvements and lower price erosion.
Selling, general and administrative (SG&A) expenses in second quarter 2001 were $57.0 million, compared to $64.4 million in the year earlier quarter. This $7.4 million decline was primarily a result of lower selling expenses and lower software amortization.
Research and development (R&D) costs were $16.4 million, or 5.9 percent of revenues.
Operating income in the second quarter of 2001 was $12.9 million, compared with $13.3 million for the same period last year. This decline is due to the factors discussed above.
Other income for the second quarter of 2001 was $1.6 million, comprised primarily of interest earned on cash balances. This compares with $4.0 million a year ago. The decline was due to investment and currency-related activities.
The tax rate for the second quarter was 32 percent. This is the rate projected for the full year 2001. This compares with a 22 percent tax rate for the second quarter 2000 and a full year 2000 rate of 5 percent. The lower 2000 rates resulted from changes in the Company’s European structure resulting from the sale of the Medical Imaging and Photo Color Systems businesses, and the Italian manufacturing facility.
Net income in the second quarter of 2001 was $9.9 million, or $0.28 per basic and diluted share, compared with net income of $13.5 million, or $0.39 per basic and $0.38 per diluted share in the second quarter 2000. The decline of $0.10 per diluted share resulted from foreign currency impacts, tax rate changes, and lower non-operating income. Adjusted for the impact of these items, net income per diluted share would have increased by $0.07 over the same period in 2000.
Comparison of Six Months Ended June 30, 2001 and 2000
In the first quarter of 2001, the Company recorded special charges related to accelerated amortization associated with the abandonment of certain capitalized software (see Note 10 to Consolidated Financial Statements). The $5.7 million charge for this amortization is recorded in selling, general, and administrative expenses.
On a year to date basis, net revenues of $583.3 million declined 8.2 percent from last year’s $635.7 million. As a result of difficult economic conditions, the Company experienced lower demand for its mature products, which comprised most of the decline as compared to the prior year. During the first six months of 2001, the Company experienced negative effects of changes in currency exchange rates of approximately 2 percent and price declines of almost 9 percent. Increases in newer product revenues of 17 percent over the prior year, were offset partially by declines in mature product revenues, for total volume increases of approximately 3 percent. The Company’s current outlook is for full-year 2001 revenues to be down slightly compared to 2000.
Data Storage and Information Management revenues decreased 4.2 percent to $425.9 million from $444.6 million a year ago. The revenue decline was primarily due to increased pricing pressures, reductions in sales of SuperDisk, and negative impacts of currency translation. Volume growth of 13 percent partially offset the decline, led by increased demand for optical media, and the Company’s enterprise tape cartridges.
Color Technologies revenues were $111.6 million, as compared to $144.4 million a year ago. The $32.8 million decline was primarily due to lower sales of analog proofing products, graphic arts film products, and plates. Strong digital proofing product sales partially offset the overall decline. The Color Technologies segment was particularly impacted by the difficult economic conditions.
Digital Solutions and Services revenues declined $4.9 million to $43.8 million. The decrease primarily resulted from the ongoing transition in the large format document imaging business from analog to digital, as well as declines in the Document Imaging business. The Digital Solutions and Services segment was also impacted by the difficult economic conditions.
Gross profit was $173.5 million, or 29.7 percent of sales, for the first six months of 2001. This compared with $196.5 million, or 30.9 percent of sales, a year ago. The gross margin percentage decrease resulted primarily from continued negative impacts from changes in foreign currency exchange rates, partially offset by productivity improvements and lower price erosion.
Selling, general and administrative (SG&A) expenses for the first six months of 2001 were $121.6 million. Excluding special charges, SG&A declined $15.7 million to $115.9 million in 2001 from $131.6 million last year. This decline was primarily a result of lower selling expenses and lower software amortization. The Company continues to expect SG&A spending to be in the range of 20 percent of revenue for the full year 2001.
Research and development (R&D) costs for the first six months of 2001 were $32.9 million. The Company expects full year R&D spending to be the range of 5-6 percent of revenues.
Operating income for the first six months of 2001 was $19.0 million. Excluding special charges, operating income for the first six months of 2001 was $24.7 million as compared to $31.2 million for the same period last year. This decline is due to the factors discussed above. Operating income for the third quarter of 2001 is expected to be higher than the prior year quarter, and for the full year, excluding special charges, to grow 5-10 percent over 2000 results to $48 to $51 million.
Other income for the first six months of 2001 was $2.7 million, as compared with $11.9 million for the same period last year. The decline was mostly attributable to $7.6 million of venture capital distributions received during the first six months of 2000, increased currency translation losses in 2001, and lower interest earned on cash balances. Due to recent declines in short term interest rates, the Company currently estimates full-year 2001 non-operating income to be below previous guidance of about $8-10 million.
The tax rate for the first six months and expected for the full-year 2001 is 32 percent. This compares with a 22 percent tax rate for the first six months of 2000 and a full year 2000 rate of 5 percent, resulting from changes in the Company’s European structure resulting from the sale of the Medical Imaging and Photo Color Systems businesses, and the Italian manufacturing facility.
Income for the first six months of 2001 was $14.8 million, or $0.43 per basic share and $0.42 per diluted share. Excluding special charges, income for the first six months of 2001 was $18.7 million, or $0.54 per basic share and $0.53 per diluted share. This compares with income, before cumulative effect of accounting change, of $33.6 million, or $0.95 per basic share and $0.93 per diluted share, for the same period in 2000. The decline resulted from tax rate changes, lower non-operating income, and foreign currency impacts. Adjusting for these items, excluding special charges, diluted earnings per share would have increased by $0.02 compared to the year-ago period. Due primarily to the increase in the full year tax rate from 5 percent in 2000 to a projected 32 percent in 2001, the full year 2001 earnings per share, excluding special charges, is expected to be below the full year 2000 earnings per share, despite anticipated improvements in operating income.
Financial Position
Accounts receivable days sales outstanding of 48 days was unchanged from December 31, 2000. Inventory days of supply of 74 days was up from 63 days as of December 31, 2000, but down 5 days from the same quarter in 2000. The increase since December 31, 2000 is due primarily to higher optical media inventory in the Data Storage and Information Management segment, as well as a planned build-up of tape products at one manufacturing plant in anticipation of the relocation of some of the work to another facility.
The Company did not repurchase any shares of common stock during the first six months of 2001. Authorization to repurchase approximately 3.2 million shares remains under the terms of the existing stock repurchase program.
Liquidity
Cash provided by operating activities was $89.2 million during the six months ended June 30, 2001 compared with $90.6 million during the same period in 2000. Depreciation and amortization was $30.1 million in the first six months of 2001 compared with $34.8 million in 2000. Amortization in 2001 includes $5.7 million of special charges related to the accelerated amortization discussed above. Depreciation and amortization, excluding the special charge, is expected to be in the range of $50 million for the full year 2001. Changes in working capital provided $44.3 million during the first six months of 2001, as compared with $19.0 million in the comparable period of 2000. This increase includes two one-time benefits, including a $15.1 million income tax refund and the reclassification of $11.0 million of restricted cash from other current assets to cash and equivalents, which was previously used as collateral for local borrowings of debt in an international subsidiary. For the six months ended June 30, 2001, the Company made total cash payments of $9.1 million associated with its restructuring programs, as compared to $10.0 million in the first six months of 2000.
Cash used by investing activities was $23.3 million for the six months ended June 30, 2001, primarily consisting of capital expenditures of $20.7 million. This compares to $29.2 million used for investing activities during the same period last year, primarily consisting of capital expenditures of $28.7 million. Capital expenditures are expected to be in the range of $45 million for the full year 2001.
Net financing activities during the first six months of 2001 used cash of $5.1 million compared with a $43.1 million use of cash in the comparable 2000 period. Financing activities in the first six months of 2000 consisted primarily of the purchase of treasury stock under an existing repurchase program. There were no shares purchased in the first six months of 2001.
The Company has a Loan and Security Agreement (the Loan Agreement) with a group of banks. The Loan Agreement provides for revolving credit, including letters of credit, with borrowing availability based on eligible accounts receivable, inventory and manufacturing machinery and equipment not to exceed $175.0 million. Borrowing availability at June 30, 2001 was $71.0 million. No borrowings were outstanding under the Loan Agreement as of June 30, 2001. The Loan Agreement expires December 31, 2001.
In addition, the Company has arranged for local borrowings of debt for certain subsidiaries. As of June 30, 2001, $14.3 million of short-term borrowings were outstanding under such arrangements, as compared to $23.7 million as of December 31, 2000.
As of June 30, 2001 the Company’s ratio of debt to total capital was 2.1 percent, down from 3.5 percent at December 31, 2000, primarily due to the decline in outstanding short-term debt. The Company expects that cash and equivalents, together with cash flow from operations and availability of borrowings under its current and future sources of financing, will provide liquidity sufficient to operate the Company for the foreseeable future.
Derivative Financial Instruments
In conjunction with the adoption of SFAS No. 133 (see Note 9 to Consolidated Financial Statements), the Company revised its foreign currency hedging policy to allow for the hedging of anticipated transactions (“cash flow hedging”) in addition to booked transactions (“transaction hedging”). The Company has begun to use cash flow hedging to reduce foreign currency exchange risks for 2001, and may further expand its use of cash flow hedging in the future. The objective of the currency hedging is to reduce the fluctuations in earnings and cash flows caused by volatility in exchange rates; however, no assurance can be given that these risk management activities will offset more than a portion of the adverse financial impact.
Euro Conversion Status
On January 1, 1999, 11 of the 15 member countries of the European Union adopted the Euro as their new common currency. The Euro is trading on currency exchanges and can be used for non-cash transactions. Local currencies will remain legal tender until December 31, 2001. By no later than December 31, 2001, participating countries will issue new Euro-denominated bills for use in cash transactions. By no later than July 1, 2002, participating countries will begin using the Euro as the legal tender and will withdraw all legacy currencies.
The Euro conversion may lead to increased competition between countries and potential erosion of margins as prices in different countries are more transparent. The Company is reviewing its marketing strategies to address possible increased competition and is also reviewing and testing its software compatibility with the Euro conversion. The Company does not expect that the Euro conversion will have a material impact on the Company’s results of operations or financial position.
New Accounting Pronouncements
In June 2001, the Financial Accounting Standards Board (FASB) issued SFAS No. 141, “Business Combinations,” which addresses accounting and financial reporting for business combinations. This statement is effective in its entirety for the Company on January 1, 2002. Also in June 2001, the FASB issued SFAS No. 142, “Goodwill and Other Intangible Assets,” which addresses accounting and financial reporting for intangible assets acquired individually or with a group of other assets, except for those acquired in a business combination. This statement is effective in its entirety for the Company on January 1, 2002. The Company does not believe that adoption of these statements will have a material impact on its results of operations or financial position.
Forward-Looking Statements
Certain information contained in this report which does not relate to historical financial information may be deemed to constitute forward-looking statements. The words or phrases “will likely result”, “are expected to”, “will continue”, “is anticipated”, “estimate”, “project”, “believe” or similar expressions identify “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from historical results, and those presently anticipated or projected.
The Company wishes to caution readers not to place undue reliance on any such forward looking statements, which speak only as of the date made. Among the factors that could cause the Company’s actual results in the future to differ materially from any opinions or statements expressed with respect to future periods are continuing uncertainty in global economic conditions that make it particularly difficult to predict product demand, the Company's ability to meet its cost reduction and revenue growth targets, and its ability to implement its restructuring program on a timely basis and to achieve the projected benefits, its ability to introduce new offerings in a timely manner, the competitive pricing environment, foreign currency fluctuations, the outcome of litigation, the resolution of disputes associated with the sale of the Medical Imaging Systems business, the ready availability and price of energy, the ability of Imation to secure adequate supply of certain high demand products, the market acceptance of newly introduced product and service offerings, the rate of decline for certain existing products, pricing transparencies resulting from the Euro conversion, as well as various factors set forth in the Company's filings with the Securities and Exchange Commission, including its 2000 Annual Report on Form 10-K.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Item 3. “Legal Proceedings” included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2000.
The Company is also the subject of various pending or threatened legal actions in the ordinary course of its business. All such matters are subject to many uncertainties and outcomes that are not predictable with assurance. Consequently, the Company is unable to ascertain the ultimate aggregate amount of any monetary liability or financial impact that may be incurred by the Company with respect to these matters. While these matters could materially affect operating results of any one quarter when resolved in future periods, it is management’s opinion that after final disposition, any monetary liability or financial impact to the Company beyond that provided in the Condensed Consolidated Balance Sheet as of June 30, 2001 would not be material to the Company’s financial position or annual results of operations or cash flows.
Items 2-5. Not Applicable
Item 6(a). Exhibits
The following documents are filed as exhibits to this Report.
| 10.1 | Separation Agreement between Steven D. Ladwig and the Company |
| | |
| 15.1 | An awareness letter from the Company’s independent accountants regarding unaudited interim financial statements. |
(b) No reports on Form 8-K were filed during the quarter ended June 30, 2001.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | Imation Corp. |
| | |
|
| | | (REGISTRANT) |
| | | |
Date: | July 31, 2001 | By: | /s/ Robert L. Edwards |
| | |
|
| | | Robert L. Edwards |
| | | Senior Vice President, Chief Financial Officer and Chief Administrative Officer |
EXHIBIT INDEX
Exhibit Number | Description |
|
|
| |
10.1 | Separation Agreement between Steven D. Ladwig and the Company |
15.1 | An awareness letter from the Company’s independent accountants regarding unaudited interim financial statements. |